Holen Sie sich die Stockscreener-App
41.10
0.98%
0.40
Schlusskurs vom Vortag:
$40.70
Offen:
$40.44
24-Stunden-Volumen:
3.26M
Relative Volume:
1.44
Marktkapitalisierung:
$6.26B
Einnahmen:
$3.44B
Nettoeinkommen (Verlust:
$-8.30M
KGV:
-276.40
EPS:
-0.1487
Netto-Cashflow:
$43.30M
1W Leistung:
+5.25%
1M Leistung:
+23.24%
6M Leistung:
+7.85%
1J Leistung:
+13.29%
1-Tages-Spanne:
$39.69
$41.27
1-Wochen-Bereich:
$38.67
$41.27
52-Wochen-Spanne:
$28.53
$56.22
Bruker Corp Stock (BRKR) Company Profile
Firmenname
Bruker Corp
Sektor
Branche
Telefon
978663-3660
Adresse
40 MANNING RD, BILLERICA, MA
Compare BRKR vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BRKR
Bruker Corp
|
41.10 | 6.20B | 3.44B | -8.30M | 43.30M | -0.1487 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Bruker Corp Stock (BRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-10 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2025-12-09 | Eingeleitet | Goldman | Sell |
| 2025-11-20 | Eingeleitet | Rothschild & Co Redburn | Buy |
| 2025-05-22 | Herabstufung | Citigroup | Buy → Neutral |
| 2024-12-19 | Eingeleitet | Guggenheim | Buy |
| 2024-12-10 | Eingeleitet | UBS | Neutral |
| 2024-12-05 | Hochstufung | Goldman | Sell → Neutral |
| 2024-10-15 | Eingeleitet | Barclays | Overweight |
| 2024-09-30 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-02-14 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2023-12-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2022-10-21 | Eingeleitet | UBS | Buy |
| 2022-08-22 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Market Perform |
| 2021-06-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2021-02-05 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2020-12-02 | Eingeleitet | Goldman | Sell |
| 2020-11-16 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2020-05-01 | Herabstufung | Cleveland Research | Buy → Neutral |
| 2020-04-02 | Herabstufung | Wolfe Research | Peer Perform → Underperform |
| 2020-04-01 | Herabstufung | Needham | Strong Buy → Hold |
| 2020-03-26 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2020-01-08 | Eingeleitet | Wells Fargo | Overweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Hold |
| 2019-09-26 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Hochstufung | Goldman | Sell → Neutral |
| 2019-06-24 | Bestätigt | Needham | Strong Buy |
| 2019-06-21 | Bestätigt | BofA/Merrill | Neutral |
| 2019-05-30 | Eingeleitet | Wolfe Research | Peer Perform |
| 2019-05-06 | Bestätigt | Needham | Strong Buy |
| 2019-05-03 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-03 | Hochstufung | UBS | Sell → Neutral |
| 2019-04-12 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2019-02-12 | Bestätigt | BTIG Research | Buy |
| 2019-01-03 | Eingeleitet | Needham | Strong Buy |
Alle ansehen
Bruker Corp Aktie (BRKR) Neueste Nachrichten
Bruker unveils MyGenius PRO diagnostics system - MSN
Bruker Corp stock (US1167941087): Is its scientific instruments edge strong enough for steady growth - AD HOC NEWS
Bruker, Amneal, Amphastar Pharmaceuticals, Dentsply Sirona, and PacBio Stocks Trade Up, What You Need To Know - Yahoo Finance
Bruker (BRKR) Unveils Innovations for Cancer Research at Upcomin - GuruFocus
A Look at Bruker Corp (BRKR) After 4.5% Gain -- GF Value $71.47 vs Price $40.70 - GuruFocus
Bruker Launches MyGenius PRO Automated Molecular Diagnostics System in Europe - Contract Pharma
Bruker Spatial Biology Showcases High Fidelity Spatial Data and Integrated Multi-platform Workflows for Unprecedented Multiomic Insights at AACR 2026 - 富途牛牛
Bruker unveils spatial biology workflows, opens PaintScape pre-orders - Investing.com
Bruker expands microbiology portfolio with new testing tools - Investing.com
Bruker launches automated molecular diagnostics system in Europe - Investing.com
Bruker Launches MyGenius PRO® High-Throughput Sample-to-Answer Molecular Diagnostics System at ESCMID 2026 - The Bakersfield Californian
Bruker Expands Industry-Leading MALDI Biotyper® and IR Biotyper® Workflows for Microbial Identification and Outbreak Management - ChartMill
BRKR Stock Price, Quote & Chart | BRUKER CORP (NASDAQ:BRKR) - ChartMill
Bruker Corporation (NASDAQ:BRKR) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Mark Munch Sells 2,000 Shares of Bruker (NASDAQ:BRKR) Stock - MarketBeat
Bruker (BRKR) EVP Mark Munch sells 2,000 shares after option exercise - Stock Titan
BRKR (NASDAQ: BRKR) director sale notice — 2,000 shares via option - Stock Titan
Bruker (NASDAQ:BRKR) Upgraded at TD Cowen - MarketBeat
BRKR SEC FilingsBruker Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Bruker Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Barclays Maintains Bruker Corp(BRKR.US) With Buy Rating, Cuts Target Price to $45 - 富途牛牛
Bruker Corp. Opens with 6.41% Gain, Marking Significant Gap Up in Stock Performance - Markets Mojo
Why Bruker (BRKR) Stock Is Up Today - Yahoo Finance
Bruker (BRKR) Unveils Innovative NMR Products at Experimental Co - GuruFocus
Bruker Unveils New NMR Products and Workflow Solutions at ENC 2026 - Eagle-Tribune
Bruker Corp (BSP:B2RK34) Stock News, Headlines & Updates - GuruFocus
Bruker Corporation 8-K SEC Filing: Company Details, Key Identifiers, and Listing Information (April 10, 2026) 2122 - Minichart
[ARS] BRUKER CORP SEC Filing - Stock Titan
Bruker (NASDAQ: BRKR) sets 2026 virtual meeting, pay and auditor votes - Stock Titan
Bruker Corp (BRKR) director Bernard Thierry listed in Form 3 filing - Stock Titan
Bruker (BRKR) BioSpin president to exit with $1.02M separation deal - Stock Titan
Bruker (BSP:B2RK34) Cyclically Adjusted Price-to-FCF : (As of Apr. 17, 2026) - GuruFocus
Bruker Corporation (BRKR) stock price, news, quote and history - Yahoo Finance UK
Bruker (BSP:B2RK34) Change In Other Working Capital : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker (BSP:B2RK34) Sale Of Property, Plant, Equipment : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker (BSP:B2RK34) Change In Prepaid Assets : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker (BSP:B2RK34) Purchase Of Investment : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker (BSP:B2RK34) Construction In Progress : R$0 Mil (As of Dec. 2025) - GuruFocus
Bruker (BSP:B2RK34) Asset Impairment Charge : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker Corp (BSP:B2RK34) Valuation: Significantly Undervalued - GuruFocus
Bruker (BSP:B2RK34) Net Income (Discontinued Operations) : R$0 Mil (TTM As of Dec. 2025) - GuruFocus
Bruker Corp Stock Historical Valuations - GuruFocus
Bruker Corp Stock Intrinsic Values - GuruFocus
Bruker (BSP:B2RK34) Shiller PE Ratio : (As of Apr. 10, 2026) - GuruFocus
Who's Buying or Selling Bruker Corp (BSP:B2RK34) Stock Today? - GuruFocus
Bruker Corp Stock Operating Data - GuruFocus
Bruker Corp (BSP:B2RK34) Competitors 2026 - GuruFocus
Bruker Corp (BSP:B2RK34) Stock Earnings Transcripts - GuruFocus
Bruker Corp (BSP:B2RK34) Stock Price & 30 Year Financial Data - GuruFocus
Bruker Corp (BSP:B2RK34) Stock HoldersInstitutional & Insider Ownership - GuruFocus
Bruker Corp (BSP:B2RK34) Dividend - GuruFocus
Finanzdaten der Bruker Corp-Aktie (BRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):